Neurexins: synaptic building blocks

神经毒素:突触构件

基本信息

  • 批准号:
    7764806
  • 负责人:
  • 金额:
    $ 25.09万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2006
  • 资助国家:
    美国
  • 起止时间:
    2006-04-01 至 2012-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Neurexins play an important role at the synapse, promoting adhesion and communication between neurons. More than 2000 neurexin isoforms are generated through a process called alternative splicing. WORKING MODEL: Neurexins are thought to be specificity factors determining neuron:neuron interactions because different splice variants are temporally and spatially expressed, splice variants bind different protein partners, and neurexins are present only on the pre-synaptic membrane. Crystallography has revealed that a specific surface is modulated by splicing in neurexin LNS/LG domains (modules in the extracellular region). OUR LONG TERM GOAL is to understand on an atomic level how neurexins help neurons recognize, adhere and communicate with each other as they form highly specific neural circuits. HYPOTHESES: Neurexins have specific features in their three-dimensional structure that enable them to work as specificity factors. Firstly, we hypothesize that neurexin LNS/LG domains contain a ligand binding surface that is regulated by two structural features 1) alternative splicing and 2) occupancy of a metal binding site by Ca2+. Secondly, we hypothesize that LNS/LG domains are arranged in space to organize areas of variation (produced through splicing) with respect to each other, adding an additional level of regulation. SPECIFIC AIMS: (1) Delineate the ligand binding surface in neurexin LNS/LG domains (2) Assess the relevance of the Ca2+ binding site in neurexin LNS/LG domains as a molecular switch for ligand binding. (3) Reveal how alternative splicing changes epitopes of the ligand binding surface. (4) Determine the domain arrangement in the extracellular region of neurexins. RELEVANCE: Neurexins use their atomic features to recognize and bind different partners. Neuroligin and alpha-dystroglycan, two partners that bind only specific neurexin splice variants, are associated with autism and lissencephalies. It is likely however that neurexins, through their synaptic location and essential nature, impact a much broader range of processes in humans, processes with a synaptic basis including memory, learning, drug addictive behavior and mechanisms underlying certain neurological illnesses and their psychiatric treatments. Understanding how neurexins aid synaptic function on a molecular level may ultimately guide the development of new strategies for the treatments of brain illnesses.
描述(由申请人提供):神经毒素在突触中起重要作用,促进神经元之间的粘附和通讯。超过2000种neurexin异构体通过称为选择性剪接的过程产生。工作模式:神经毒素被认为是决定神经元:神经元相互作用的特异性因子,因为不同的剪接变体在时间和空间上表达,剪接变体结合不同的蛋白质伴侣,并且神经毒素仅存在于突触前膜上。晶体学已经揭示,通过neurexin LNS/LG结构域(胞外区中的模块)中的剪接来调节特定表面。我们的长期目标是在原子水平上了解neurexins如何帮助神经元识别,粘附和相互交流,因为它们形成高度特异性的神经回路。假设:神经毒素在其三维结构中具有特定的特征,使其能够作为特异性因子发挥作用。首先,我们假设neurexin LNS/LG结构域含有受两个结构特征调节的配体结合表面:1)选择性剪接和2)Ca 2+占据金属结合位点。其次,我们假设LNS/LG结构域在空间上排列,以组织彼此之间的变异区域(通过剪接产生),增加额外的调节水平。具体目标:(1)描绘neurexin LNS/LG结构域中的配体结合表面(2)评估neurexin LNS/LG结构域中的Ca 2+结合位点作为配体结合的分子开关的相关性。(3)揭示选择性剪接如何改变配体结合表面的表位。(4)确定neurexins胞外区的结构域排列。相关性:Neurexins利用其原子特征识别和结合不同的伴侣。神经连接蛋白和α-肌营养不良蛋白聚糖,两个合作伙伴,结合只有特定的neurexin剪接变异体,与自闭症和无脑。然而,神经毒素很可能通过其突触位置和本质影响人类更广泛的过程,这些过程具有突触基础,包括记忆,学习,药物成瘾行为和某些神经疾病及其精神治疗的潜在机制。了解neurexins如何在分子水平上帮助突触功能,最终可能会指导大脑疾病治疗新策略的开发。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Gabrielle Rudenko其他文献

Gabrielle Rudenko的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Gabrielle Rudenko', 18)}}的其他基金

Acquisition of an automated crystal imager
购置自动晶体成像仪
  • 批准号:
    10410861
  • 财政年份:
    2022
  • 资助金额:
    $ 25.09万
  • 项目类别:
Molecular mechanisms of the synaptic organizer alpha-neurexin
突触组织者α-neurexin的分子机制
  • 批准号:
    8813887
  • 财政年份:
    2014
  • 资助金额:
    $ 25.09万
  • 项目类别:
Molecular mechanisms of the synaptic organizer alpha-neurexin
突触组织者α-neurexin的分子机制
  • 批准号:
    8339687
  • 财政年份:
    2006
  • 资助金额:
    $ 25.09万
  • 项目类别:
Synaptic Organizers: Dynamic Regulation of Trans-synaptic Bridges
突触组织者:跨突触桥的动态调节
  • 批准号:
    9910228
  • 财政年份:
    2006
  • 资助金额:
    $ 25.09万
  • 项目类别:
Neurexins: synaptic building blocks
神经毒素:突触构件
  • 批准号:
    7871043
  • 财政年份:
    2006
  • 资助金额:
    $ 25.09万
  • 项目类别:
Molecular mechanisms of the synaptic organizer alpha-neurexin
突触组织者α-neurexin的分子机制
  • 批准号:
    8700516
  • 财政年份:
    2006
  • 资助金额:
    $ 25.09万
  • 项目类别:
Neurexins: synaptic building blocks
神经毒素:突触构件
  • 批准号:
    7085839
  • 财政年份:
    2006
  • 资助金额:
    $ 25.09万
  • 项目类别:
Synaptic Organizers: Dynamic Regulation of Trans-synaptic Bridges
突触组织者:跨突触桥的动态调节
  • 批准号:
    10397995
  • 财政年份:
    2006
  • 资助金额:
    $ 25.09万
  • 项目类别:
Molecular mechanisms of the synaptic organizer alpha-neurexin
突触组织者α-neurexin的分子机制
  • 批准号:
    8496875
  • 财政年份:
    2006
  • 资助金额:
    $ 25.09万
  • 项目类别:
Neurexins: synaptic building blocks
神经毒素:突触构件
  • 批准号:
    7215204
  • 财政年份:
    2006
  • 资助金额:
    $ 25.09万
  • 项目类别:

相似海外基金

How tensins transform focal adhesions into fibrillar adhesions and phase separate to form new adhesion signalling hubs.
张力蛋白如何将粘着斑转化为纤维状粘连并相分离以形成新的粘连信号中枢。
  • 批准号:
    BB/Y004841/1
  • 财政年份:
    2024
  • 资助金额:
    $ 25.09万
  • 项目类别:
    Research Grant
Defining a role for non-canonical mTORC1 activity at focal adhesions
定义非典型 mTORC1 活性在粘着斑中的作用
  • 批准号:
    BB/Y001427/1
  • 财政年份:
    2024
  • 资助金额:
    $ 25.09万
  • 项目类别:
    Research Grant
How tensins transform focal adhesions into fibrillar adhesions and phase separate to form new adhesion signalling hubs.
张力蛋白如何将粘着斑转化为纤维状粘连并相分离以形成新的粘连信号中枢。
  • 批准号:
    BB/Y005414/1
  • 财政年份:
    2024
  • 资助金额:
    $ 25.09万
  • 项目类别:
    Research Grant
Development of a single-use, ready-to-use, sterile, dual chamber, dual syringe sprayable hydrogel to prevent postsurgical cardiac adhesions.
开发一次性、即用型、无菌、双室、双注射器可喷雾水凝胶,以防止术后心脏粘连。
  • 批准号:
    10669829
  • 财政年份:
    2023
  • 资助金额:
    $ 25.09万
  • 项目类别:
Regulating axon guidance through local translation at adhesions
通过粘连处的局部翻译调节轴突引导
  • 批准号:
    10587090
  • 财政年份:
    2023
  • 资助金额:
    $ 25.09万
  • 项目类别:
Improving Maternal Outcomes of Cesarean Delivery with the Prevention of Postoperative Adhesions
通过预防术后粘连改善剖宫产的产妇结局
  • 批准号:
    10821599
  • 财政年份:
    2023
  • 资助金额:
    $ 25.09万
  • 项目类别:
Regulating axon guidance through local translation at adhesions
通过粘连处的局部翻译调节轴突引导
  • 批准号:
    10841832
  • 财政年份:
    2023
  • 资助金额:
    $ 25.09万
  • 项目类别:
Prevention of Intraabdominal Adhesions via Release of Novel Anti-Inflammatory from Surface Eroding Polymer Solid Barrier
通过从表面侵蚀聚合物固体屏障中释放新型抗炎剂来预防腹内粘连
  • 批准号:
    10532480
  • 财政年份:
    2022
  • 资助金额:
    $ 25.09万
  • 项目类别:
I-Corps: A Sprayable Tissue-Binding Hydrogel to Prevent Postsurgical Cardiac Adhesions
I-Corps:一种可喷雾的组织结合水凝胶,可防止术后心脏粘连
  • 批准号:
    10741261
  • 财政年份:
    2022
  • 资助金额:
    $ 25.09万
  • 项目类别:
Sprayable Polymer Blends for Prevention of Site Specific Surgical Adhesions
用于预防特定部位手术粘连的可喷涂聚合物共混物
  • 批准号:
    10674894
  • 财政年份:
    2022
  • 资助金额:
    $ 25.09万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了